Novartis is to collaborate with the Banner Alzheimer’s Institute (BAI) to test two of the Swiss company’s investigational anti-amyloid treatments. …

Targacept is dropping a once promising Alzheimer’s drug from further clinical trials after it failed to beat Pfizer’s Aricept (donepezil) …

NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …

The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …

Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …

Alzheimer’s Research UK has launched a new Facebook app which allows users to see what it is like to suffer …

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …
US researchers have developed a blood test which they say is able to predict with overwhelming accuracy if someone will …

Eisai and Biogen Idec have joined forces to look for new Alzheimer’s treatments, developing and commercialising two of the Japanese …

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …
AC Immune, a privately-held biotech based in Switzerland, has launched the world’s first trial of a vaccine against a protein …

UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …
Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …